World Journal of Virology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 445614

Number of visits today: 144

Number of downloads: 229652

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Heyckendorf J, Georghiou SB, Frahm N, Heinrich N, Kontsevaya I, Reimann M, Holtzman D, Imperial M, Cirillo DM, Gillespie SH, Ruhwald M; UNITE4TB Consortium. Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clin Microbiol Rev 2022;35:e0022721. [PMID: 35311552 DOI: 10.1128/cmr.00227-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]

For:

Heyckendorf J, Georghiou SB, Frahm N, Heinrich N, Kontsevaya I, Reimann M, Holtzman D, Imperial M, Cirillo DM, Gillespie SH, Ruhwald M; UNITE4TB Consortium. Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clin Microbiol Rev 2022;35:e0022721. [PMID: 35311552 DOI: 10.1128/cmr.00227-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]

Number	Citing Articles
1	Fu L, Feng Y, Ren T, Yang M, Yang Q, Lin Y, Zeng H, Zhang J, Liu L, Li Q, He M, Zhang P, Chen H, Deng G. Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study. Biosci Trends 2023;17:73-7. [PMID: 36596559 DOI: 10.5582/bst.2022.01476] [Reference Citation Analysis]
2	Valdemar-Aguilar CM, Manisekaran R, Acosta-Torres LS, López-Marín LM. Spotlight on mycobacterial lipid exploitation using nanotechnology for diagnosis, vaccines, and treatments. Nanomedicine 2023;48:102653. [PMID: 36646193 DOI: 10.1016/j.nano.2023.102653] [Reference Citation Analysis]
3	Fang Y, Tang Y, Wang N, Luo Q, Tang L, Yang X, Zhang J, You X, Wang Y, Su B, Sha W. Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27 - CD38 + IFN- γ + CD4 + T cells before and after anti-tuberculosis treatment.. [DOI: 10.21203/rs.3.rs-2467536/v1] [Reference Citation Analysis]
4	Alffenaar JC, de Steenwinkel JEM, Diacon AH, Simonsson USH, Srivastava S, Wicha SG. Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies. Front Pharmacol 2022;13:1063453. [PMID: 36569287 DOI: 10.3389/fphar.2022.1063453] [Reference Citation Analysis]
5	Mishra S, Saito K. Clinically encountered growth phenotypes of tuberculosis-causing bacilli and their in vitro study: A review. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1029111] [Reference Citation Analysis]
6	Shunxian Zhang, Lei Qiu, Dingzhong Wu, Shaoyan Zhang, Chenhui Pan, Cui Li, Heping Xiao, Fuli Huang, Hua Wang, Feng Jiang, Huiyong Zhang, Peiyong Zheng, Zhenhui Lu. Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020. China CDC Wkly 2022;4. [PMID: 36426288 DOI: 10.46234/ccdcw2022.187] [Reference Citation Analysis]
7	Hu Z, Fan X. Editorial: Novel approaches to rapid diagnosis and treatment monitoring of active tuberculosis, vol II. Front Microbiol 2022;13:1044314. [DOI: 10.3389/fmicb.2022.1044314] [Reference Citation Analysis]